Prof. Dr. med. Georg Schett



Organisation


Lehrstuhl für Innere Medizin III


Awards / Honours


2018 : ERC Synergy Grant


Project member


MoJo 3D: Modular composite Joint 3D
Dr. Tobias Fey; PD Dr. med. Kolja Gelse
(01/01/2017 - 31/12/2019)


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 45 Go to next page Go to last page

Liang, R.f., Kagwiria, R., Zehender, A., Dees, C., Bergmann, C., Ramming, A.,... Distler, J. (2019). Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2019-215066
Löhr, S., Ekici, A.B., Uebe, S., Büttner, C., Köhm, M., Behrens, F.,... Hüffmeier, U. (2019). Analyses of association of psoriatic arthritis and psoriasis vulgaris with functional NCF1 variants. Rheumatology, 58(5), 915-917. https://dx.doi.org/10.1093/rheumatology/key448
Sokolova, M., Nas, K., Luo, Y., Simon, D., Zhao, Y., Rech, J.,... Schett, G. (2019). A SET OF INFLAMMATORY MARKERS ALLOWING TO DETECT SYSTEMIC INFLAMMATION IN PSORIATIC SKIN, ENTHESEAL AND JOINT DISEASE IN THE ABSENCE OF CRP AND THEIR LINK TO CLINICAL DISEASE MANIFESTATION. In ANNALS OF THE RHEUMATIC DISEASES (pp. 175-176). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Heinzerling, L., De Toni, E.N., Schett, G., Hundorfean, G., & Zimmer, L. (2019). Checkpoint Inhibitors. Deutsches Ärzteblatt international, 116(8), 119-126. https://dx.doi.org/10.3238/arztebl.2019.0119
Heinzerling, L., De Toni, E.N., Schett, G., Hundorfean, G., & Zimmer, L. (2019). Checkpoint Inhibitors The Diagnosis and Treatment of Side Effects. Deutsches Ärzteblatt international, 116(8), 119-+. https://dx.doi.org/10.3238/arztebl.2019.0119
Simon, D., Schett, G., & Kleyer, A. (2019). Clinical Images: Development of joint erosions in the preclinical phase of rheumatoid arthritis depicted by cinematic rendering. Arthritis and Rheumatology. https://dx.doi.org/10.1002/art.41001
Kampylafka, E., Englbrecht, M., Tascilar, K., Lerchen, V., Linz, C., Kleyer, A.,... Hueber, A. (2019). COMPARATIVE CHANGE IN QUALITY OF LIFE MEASURES IN PRECLINICAL AND ESTABLISHED PSORIATIC ARTHRITIS PATIENTSUNDER SECUKINUMAB TREATMENT. DATA DERIVED FROM THE PROSPECTIVE OPEN LABEL PSARTROS STUDY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1845-1845). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Hagen, M., Englbrecht, M., Haschka, J., Reiser, M., Kleyer, A., Hueber, A.,... Rech, J. (2019). Cost-effective tapering algorithm in patients with rheumatoid arthritis: Combination of multibiomarker disease activity score and autoantibody status. Journal of Rheumatology, 46(5), 460-466. https://dx.doi.org/10.3899/jrheum.180028
Kampylafka, E., Simon, D., D'Oliveira, I., Linz, C., Lerchen, V., Englbrecht, M.,... Hueber, A. (2019). Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation - Data from the prospective IVEPSA study. Arthritis Research & Therapy, 21(1). https://dx.doi.org/10.1186/s13075-019-1957-0
Ritchlin, C.T., Kavanaugh, A., Merola, J.F., Schett, G., Scher, J.U., Warren, R.B.,... Mcinnes, I. (2019). DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAIVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 127-128). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.

Last updated on 2018-11-10 at 13:44